Loteprednol Etabonate Nanoparticles: Optimization via Box-Behnken Design Response Surface Methodology and Physicochemical Characterization. [electronic resource]
- Current drug delivery 2017
- 676-689 p. digital
Publication Type: Journal Article
1875-5704
10.2174/1567201813666160801125235 doi
Administration, Ophthalmic Drug Carriers Drug Liberation Lactic Acid Loteprednol Etabonate--chemistry Nanoparticles Particle Size Polyglycolic Acid Polymers